logo

For the Inventor, By the Inventor

Bondy, France

Jean-Claude Gasc

This inventor holds 17 USPTO granted patents. Top assignees: Roussel Uclaf, Other. Active years: 1976-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Claude Gasc. Retrieved from https://idiyas.com/inventor/jean-claude-gasc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 123(Granted Patents)


Company Filing History:

goldMedal16 out of 854 
 
Roussel Uclaf
 patents
silverMedal1 out of 834,453 
Other
 patents

Years Active: 1976-1991

Loading Chart...
17 patents (USPTO):Explore Patents
1. 5064853 - 4(2-indolyl)2-amino-pentanedioic acids and cholecyostokinin use thereof (1991-11-12),
2. 4988692 - 2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepines (1991-01-29),
3. 4855302 - Certain azaspirodecane compounds and a method of inducing an anxiolytic (1989-08-08),
4. 4839358 - Alpha-mercaptomethyl-benzene propanamides, pharmaceutical compositions (1989-06-13),
5. 4736042 - 2,3-dihydro indoles (1988-04-05),
6. 4699907 - 4-morpholinyl-1H-indoles, pharmaceutical compositions and use (1987-10-13),
7. 4591589 - 2-aryl pyrazolo[4,3-c]cinnolin-3-ones (1986-05-27),
8. 4588731 - Derivatives of isoxazolo[4,5-c]quinoline(2H)-3-one and method of (1986-05-13),
9. 4503053 - C-Homo-9-oxa-ergolines (1985-03-05),
10. 4412988 - Hexapeptides (1983-11-01),
11. 4349545 - Novel erythromycin a derivatives (1982-09-14),
12. 4242331 - Aminoglycosides and method of use (1980-12-30),
13. 4146617 - Desoxystreptamine derivatives, salts, pharmaceutical compositions and (1979-03-27),
14. 4064339 - Antibiotic aminoglycosides, processes of preparation and pharmaceutical (1977-12-20),
15. 4031210 - Antibiotic aminoglycosides, processes of preparation and pharmaceutical (1977-06-21),

Title: **Jean-Claude Gasc: Innovator in Pharmaceutical Compounds**

Introduction

Jean-Claude Gasc, an accomplished inventor based in Bondy, France, holds an impressive portfolio of 17 patents. His work primarily focuses on the development of novel pharmaceutical compounds, particularly in the field of cholecystokinin-related functionalities. Gasc's innovative contributions have significantly advanced the understanding and potential of various therapeutic agents.

Latest Patents

Among Jean-Claude Gasc's most notable recent patents are two significant discoveries. The first, titled "4(2-indolyl)2-amino-pentanedioic acids and cholecyostokinin use thereof," encompasses a series of compounds with various isomeric forms, designed to exhibit cholecystokinin agonistic or antagonistic activity. The second, "2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepines," involves a class of compounds that also has the potential for cholecystokinin antagonistic activity. Both patents highlight Gasc's commitment to advancing pharmaceutical science through innovative chemical research.

Career Highlights

Throughout his career, Jean-Claude Gasc has worked with prominent companies, including Roussel Uclaf. His contributions have not only generated numerous patents but have also paved the way for new therapeutic strategies in medicine. His extensive knowledge and experience in medicinal chemistry have made him a respected figure in the field.

Collaborations

Gasc has collaborated with several esteemed colleagues, notably Daniel Humbert and Lucien Nedelec. These partnerships have enhanced the quality and reach of his research, leading to groundbreaking developments in pharmaceutical innovation.

Conclusion

With a solid foundation of patents and collaborations, Jean-Claude Gasc stands out as a significant inventor in the pharmaceutical domain. His innovative spirit and dedication to research continue to influence the field, promoting advancements that can improve health outcomes and expand therapeutic options. Gasc's work exemplifies the pivotal role of inventors in driving innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…